ArticleTherapeutic advances in drug safety2022

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies.

Kayeong Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.